Sunesis Pharmaceuticals to Present at the Needham 5th Annual Biotechnology & Medical Technology Conference
14 June 2006 - 7:30AM
PR Newswire (US)
SOUTH SAN FRANCISCO, Calif., June 13 /PRNewswire-FirstCall/ --
Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) today announced that
Daniel N. Swisher, Jr., Chief Executive Officer and President, will
present a company update at the Needham 5th Annual Biotechnology
and Medical Technology Conference on June 14, 2006 at 11:00 a.m.
Eastern Time at the New York Palace Hotel in New York, NY.
Interested parties may access a webcast of the presentation by
visiting the Sunesis website at http://ir.sunesis.com/. A replay of
the webcast will be archived on the "Calendar of Events" page in
the Investors and Media section of the Sunesis website for two
weeks until June 28, 2006. About Sunesis Pharmaceuticals Sunesis is
a clinical-stage biopharmaceutical company focused on the
discovery, development and commercialization of novel small
molecule therapeutics for oncology and other serious diseases.
Sunesis has built a broad product candidate portfolio through
internal discovery and in-licensing of novel cancer therapeutics.
Sunesis is advancing its product candidates through in-house
research and development efforts and strategic collaborations with
leading pharmaceutical and biopharmaceutical companies. For further
information on Sunesis Pharmaceuticals, please visit
http://www.sunesis.com/. Forward-Looking Statements This press
release may contain forward-looking statements that involve
substantial risks and uncertainties. Sunesis may not actually
achieve the plans, intentions or expectations contained in such
forward-looking statements. Actual results or events could differ
materially from the plans, intentions and expectations contained in
such forward-looking statements. Sunesis does not assume any
obligation to update any such forward-looking statements.
DATASOURCE: Sunesis Pharmaceuticals, Inc. CONTACT: investors, Eric
Bjerkholt, CFO of Sunesis Pharmaceuticals, Inc., +1-650-266-3717;
or media, Karen L. Bergman, +1-650-575-1509, or Michelle Corral,
+1-415-794-8662, both of BCC Partners, for Sunesis Pharmaceuticals,
Inc. Web site: http://www.sunesis.com/
Copyright
Sunesis Pharmaceuticals (NASDAQ:SNSS)
Historical Stock Chart
From Sep 2024 to Oct 2024
Sunesis Pharmaceuticals (NASDAQ:SNSS)
Historical Stock Chart
From Oct 2023 to Oct 2024
Real-Time news about Sunesis Pharmaceuticals Inc (NASDAQ): 0 recent articles
More Sunesis Pharmaceuticals (MM) News Articles